, Japan
5 views

Fujitsu, Tokyo Shinagawa to develop AI-supported diagnosis of COVID-19 pneumonia

The system is expected to deliver early detection of cases, even when the probablity of infection is low.

IT services provider Fujitsu and Tokyo Shinagawa Hospital has announced plans to launch a joint R&D project for AI technology to support diagnostic imaging via chest CT for COVID-19 pneumonia, Fujitsu said in a press release.

Fujitsu and Tokyo Shinagawa anticipate that the system will deliver early detection of cases of COVID-19 pneumonia based on chest CT image findings, even in cases in which the possibility of infection is determined to be low upon initial examination.

Normally, doctors make lung disease diagnoses based on the characteristics of the shadows in the lesion on the patient's chest CT image. In addition to identifying abnormalities, they visually check hundreds of chest CT images per patient to understand the three-dimensional distribution of shadows throughout the lung.

A growing demand for technologies that reduce the burden on doctors and support speedy decision-making has accompanied the spread of the novel coronavirus. It is also important to identify novel coronavirus pneumonia from a CT scan of the patient's chest if there is a low likelihood of a novel coronavirus infection during the examination and PCR testing is not performed.

In response to the need for diagnostic support, the AI-assisted diagnostic imaging technology will be developed which is slated to learn from the past CT image data at the hospital. As the AI learns from this data about the possibility of COVID-19 pneumonia, Fujitsu and Tokyo Shinagawa Hospital will work together to evaluate the effectiveness of the technology.

Fujitsu is considering the commercialisation of this technology as a healthcare solution by linking it with electronic medical record information, the press release added.
 

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Get Health Care Asia Magazine in your inbox
It was recognised for its cutting-edge medical device packaging design, Dispenser Integrated System Kit (DISK).
There has been an expanding research base across India, China, and Japan.
It combines third-party assured data verification with blockchain technology.
Consultation is available for only $0.014 (INR1).
The number of hospitals operating on hip fracture that have access to a fracture liaison service has been steadily rising from 2013 to 2020.
GMT Manila’s award-winning initiative, in collaboration with Endec Inc. and Scilore LLC, is a rapidly deployable turnkey solution for RT-PCR Testing that made it more available across the Philippines. 
As The National Cardiovascular Referral Center in Indonesia, NCCHK has been acknowledged by Asia's Healthcare Industry.
Currently, North America dominates the market across the globe.
More medical devices are being bought for home use.
It has also introduced a new hotline service.
The firm was recognised for its multiple initiatives in braving the COVID-19 crisis.
It took home the Training Initiative of the Year trophy for its non-invasive therapy treatment for benign prostatic hyperplasia (BPH).
The country’s SII makes up about half of Covax supply.
It owns 39 hospitals and eight clinics across England, Wales, and Scotland.
The company plans to set up over 100 in-school clinics.